# Improving Safety and Accuracy of Stereotactic Brain Biopsies in Primary Central Nervous System Lymphoma.

> **NCT06263361** · — · RECRUITING · sponsor: **IRCCS San Raffaele** · enrollment: 15 (estimated)

## Conditions studied

- Cerebral Lymphoma

## Interventions

- **DIAGNOSTIC_TEST:** MRI imaging
- **DIAGNOSTIC_TEST:** Cerebral biopsy

## Key facts

- **NCT ID:** NCT06263361
- **Lead sponsor:** IRCCS San Raffaele
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-10-01
- **Primary completion:** 2028-12-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2025-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06263361

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06263361, "Improving Safety and Accuracy of Stereotactic Brain Biopsies in Primary Central Nervous System Lymphoma.". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT06263361. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*